Danske Bank A S Grows Holdings in Regeneron Pharmaceuticals, Inc. $REGN

Danske Bank A S increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by 78.8% in the fourth quarter, now owning 99,302 shares valued at $76,648,000. Other institutional investors also adjusted their positions in the biopharmaceutical company, which recently reported strong Q1 earnings, a new share repurchase program, and a quarterly dividend. However, concerns remain regarding competition for its EYLEA drug and several analysts have trimmed price targets.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin